Oyster Point Pharma Inc (NASDAQ: OYST) has announced the expansion of its pipeline with the introduction of Enriched Tear Film (ETF) Gene Therapy and proof-of-concept in vivo study results from its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results